PLRX
Price:
$12.87
Market Cap:
$782.51M
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an ...[Read more]
Industry
Biotechnology
IPO Date
2020-06-03
Stock Exchange
NASDAQ
Ticker
PLRX
According to Pliant Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 762.35M. This represents a change of -12.62% compared to the average of 872.41M of the last 4 quarters.
The mean historical Enterprise Value of Pliant Therapeutics, Inc. over the last ten years is 568.35M. The current 762.35M Enterprise Value has changed 13.31% with respect to the historical average. Over the past ten years (40 quarters), PLRX's Enterprise Value was at its highest in in the March 2023 quarter at 1.40B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
568.35M
Median
671.88M
Minimum
12.86M
Maximum
1.01B
Discovering the peaks and valleys of Pliant Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.16%
Maximum Annual Enterprise Value = 1.01B
Minimum Annual Increase = -41.96%
Minimum Annual Enterprise Value = 12.86M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.01B | 27.35% |
2022 | 794.30M | 80.75% |
2021 | 439.46M | -41.96% |
2020 | 757.16M | 12.69% |
2019 | 671.88M | 130.70% |
2018 | 291.24M | 2.16% |
The current Enterprise Value of Pliant Therapeutics, Inc. (PLRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
748.43M
5-year avg
734.87M
10-year avg
568.35M
Pliant Therapeutics, Inc.’s Enterprise Value is greater than Relay Therapeutics, Inc. (752.45M), greater than Stoke Therapeutics, Inc. (586.20M), greater than Black Diamond Therapeutics, Inc. (296.10M), less than Arvinas, Inc. (1.52B), greater than 89bio, Inc. (712.19M), less than Madrigal Pharmaceuticals, Inc. (4.91B), less than Arcellx, Inc. (3.80B), less than Dyne Therapeutics, Inc. (2.73B), less than Cytokinetics, Incorporated (6.96B), less than Revolution Medicines, Inc. (6.80B), less than Syndax Pharmaceuticals, Inc. (1.52B), less than Viridian Therapeutics, Inc. (813.50M), greater than Inozyme Pharma, Inc. (343.89M), greater than TCR2 Therapeutics Inc. (49.64M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (44.87M),
Company | Enterprise Value | Market cap |
---|---|---|
752.45M | $835.47M | |
586.20M | $773.92M | |
296.10M | $305.13M | |
1.52B | $1.68B | |
712.19M | $897.06M | |
4.91B | $5.30B | |
3.80B | $3.83B | |
2.73B | $3.32B | |
6.96B | $6.36B | |
6.80B | $6.99B | |
1.52B | $1.63B | |
813.50M | $900.21M | |
343.89M | $312.42M | |
49.64M | $58.11M | |
-8620212.00 | $3.57M | |
44.87M | $43.48M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pliant Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pliant Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pliant Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Pliant Therapeutics, Inc. (PLRX)?
What is the 3-year average Enterprise Value for Pliant Therapeutics, Inc. (PLRX)?
What is the 5-year average Enterprise Value for Pliant Therapeutics, Inc. (PLRX)?
How does the current Enterprise Value for Pliant Therapeutics, Inc. (PLRX) compare to its historical average?